Analysts cheered a draft statement from the Centers for Medicare and Medicaid Services (CMS) that said the government plans to pay for prostate cancer treatment Provenge, made by Seattle-based biotechnology firm Dendreon.
However, you can now do team plans that will reduce the cost based on how many people you add, and you can even pay yearly to bring it down a further 25%.